Literature DB >> 24917146

NF-κB mediates the survival of corneal myofibroblast induced by angiotensin II.

Hong-Wei Pan1, Yu-Hong Cui2, Jun-Wen Zeng3.   

Abstract

PURPOSE: To investigate the role of angiotensin II (Ang II) in the regulation of corneal myofibroblast apoptosis and the possible signaling pathway.
METHODS: Rabbit corneal myofibroblasts were cultured in vitro and the cell phenotype was identified by expression of α-smooth muscle actin (α-SMA) and formation of F-actin. The expression of Ang II type I receptor (AT1R) in keratocytes and corneal myofibroblasts were detected by immunofluorescence staining and Western blot. The effect of Ang II on corneal myofibroblast apoptosis induced by serum starvation and TNFα plus cycloheximide (CHX) was examined by TUNEL, Hoechst 33258 staining, and caspase 3/7 activity assay. The effect of Ang II on nuclear factor-κB (NF-κB)-dependent DNA binding activity and transcriptional activity was studied by electrophoresis mobility shift assay (EMSA) and luciferase reporter assay, respectively. Ang II-induced TGFβ1 secretion by corneal myofibroblasts was determined by ELISA.
RESULTS: Ang II type I receptor expression was more abundant in corneal myofibroblasts compared with keratocytes. Ang II reduced corneal myofibroblasts apoptotic response to serum starvation or treatment with TNFα plus CHX. This protective effect was attenuated in the presence of AT1R antagonist losartan or NF-κB-specific inhibitor Bay11-7082. Ang II increased NF-κB-dependent DNA-binding activity and transcriptional activity, and also increased TGFβ1 production by corneal myofibroblasts.
CONCLUSIONS: Ang II induces corneal myofibroblasts resistance to apoptosis via activating NF-κB signaling pathway, and thus should be further investigated as a possible target for therapy of corneal fibrosis. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  NF-κB; angiotensin II; apoptosis; corneal fibrosis; corneal myofibroblasts

Mesh:

Substances:

Year:  2014        PMID: 24917146     DOI: 10.1167/iovs.13-13735

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  NF-κB activation persists into the remodeling phase of tendon healing and promotes myofibroblast survival.

Authors:  Katherine T Best; Anne E C Nichols; Emma Knapp; Warren C Hammert; Constantinos Ketonis; Jennifer H Jonason; Hani A Awad; Alayna E Loiselle
Journal:  Sci Signal       Date:  2020-11-17       Impact factor: 8.192

2.  TRAF4 promotes lung cancer aggressiveness by modulating tumor microenvironment in normal fibroblasts.

Authors:  EunGi Kim; Wanyeon Kim; Sungmin Lee; Jahyun Chun; JiHoon Kang; Gaeul Park; IkJoon Han; Hee Jung Yang; HyeSook Youn; BuHyun Youn
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

Review 3.  Pathobiology of wound healing after glaucoma filtration surgery.

Authors:  Osamu Yamanaka; Ai Kitano-Izutani; Katsuo Tomoyose; Peter S Reinach
Journal:  BMC Ophthalmol       Date:  2015-12-17       Impact factor: 2.209

4.  Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma.

Authors:  Harry A Quigley; Ian F Pitha; Derek S Welsbie; Cathy Nguyen; Matthew R Steinhart; Thao D Nguyen; Mary Ellen Pease; Ericka N Oglesby; Cynthia A Berlinicke; Katherine L Mitchell; Jessica Kim; Joan J Jefferys; Elizabeth C Kimball
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.